Entourage Extends Supply Deal With Tilray's HEXO To Ensure Top-Quality Cannabis Products
Portfolio Pulse from Jelena Martinovic
Entourage Health Corp. has extended its supply agreement with HEXO Corp., securing ongoing access to high-quality cannabis biomass for its product portfolio. The prices of all products supplied under the agreement are fixed but subject to adjustments depending on production costs. Following HEXO's acquisition by Tilray Brands Inc., Entourage shifted its sourcing strategy, now obtaining cannabis from Tilray cultivation sites. HEXO's obligations under the deal have been assigned to Aphria Inc., Tilray's principal operating entity.
September 15, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Entourage Health Corp. has extended its supply agreement with HEXO Corp., ensuring a steady supply of high-quality cannabis biomass for its products. This could potentially boost Entourage's product quality and market position.
The extended supply agreement ensures Entourage's access to high-quality cannabis, which is crucial for its product quality and customer satisfaction. This could potentially enhance its market position and positively impact its stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Following HEXO's acquisition by Tilray Brands Inc., Entourage Health Corp. has shifted its sourcing strategy, now obtaining cannabis from Tilray cultivation sites. This could potentially increase Tilray's sales and revenue.
Entourage's decision to source cannabis from Tilray cultivation sites following HEXO's acquisition by Tilray could potentially increase Tilray's sales and revenue, positively impacting its stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75